FT

Biogen Alzheimer’s drug in doubt after criticism from expert panel

Photo of Financial Times Financial Times
0 Less than a minute

Scientists express scepticism of trial data and US regulatory process at fiery hearing

Photo of Financial Times Financial Times
0 Less than a minute
Photo of Financial Times

Financial Times

Related Articles

A step forward on global corporation tax reform

Former officer who fatally shot Daunte Wright to face manslaughter charge

US states to watch: where the campaigns are fighting it out

Trading boom propels Deutsche Bank to first profit in six years

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button